ClearTrial Selected to Chair Advanced Forum on Clinical Study Resource Planning at DIA 47th Annual MeetingDemonstrates ClearTrial domain expertise in area critical to improving development efficiency and reducing study costs CHICAGO, IL – June 16, 2011 ClearTrial, the leading provider of software for the planning, forecasting, and tracking of clinical project and financial performance, today announced that Todd Reul, Director, Clinical Services at ClearTrial, will chair the forum "When, How, and Why: Optimizing Resource Planning to Get the Most from Your Existing Resources" at the DIA 47th Annual Meeting in Chicago, Illinois. Each year the DIA Annual Meeting attracts thousands of professionals from around the world involved in the discovery, development, and lifecycle management of pharmaceuticals, medical devices, and related products. These professionals come to the conference to discover new ideas and best practices for innovation in the life sciences.
"In today’s economy, biopharmaceutical and medical device companies are under increased pressure to be as efficient and cost-effective as possible," observed Andrew Grygiel, Vice President of Marketing and Product Management for ClearTrial. "This valuable forum at DIA will show how effective resource planning can help these companies make insightful, strategic business decisions to extract the most out of their limited resources." About ClearTrial® ClearTrial is the leading provider of Clinical Trial Operations (CTO) software, an integrated system for clinical operations planning, forecasting, outsourcing, and project tracking. ClearTrial’s award-winning software helps life sciences companies streamline their clinical operations from Plan to Payment™ without sacrificing quality of results, providing executives and functional leaders in clinical operations, resource planning, finance, outsourcing, and project management with a common platform that promotes speed, accuracy, and consistency throughout the organization. For more information visit http://www.cleartrial.com. ClearTrial® and the ClearTrial logo are registered trademarks owned by ClearTrial, LLC, which may be registered in certain jurisdictions. Any other company or product names mentioned in this release are hereby acknowledged as registered trademarks or trademarks of their respective owners. For more information contact: Mike Lange |
